Literature DB >> 17669620

Maternal and fetal blood and organ toluene levels in rats following acute and repeated binge inhalation exposure.

Scott E Bowen1, John H Hannigan, Susan Irtenkauf.   

Abstract

Inhalation of organic solvents is a persistent form of drug abuse with particular concern being the abuse of inhalants by women of child-bearing age. While studies have begun assessing postnatal outcomes of offspring exposed prenatally to inhalants, relatively little is known about the distribution of toluene in blood and body tissues of pregnant, inhalant-abusing women, or in the fetuses. The present study assessed the tissue toluene levels attained following brief toluene exposures using a pre-clinical rat model of maternal inhalant abuse. Timed-pregnant Sprague-Dawley rats were exposed to toluene at 8000 or 12,000 parts per million (ppm) for 15, 30 or 45 min/exposure. Exposures occurred twice each day from gestational day 8 (GD8) through GD20. Immediately following the second exposure on GD8, GD14 and GD20 blood was taken from the saphenous vein of the dams. Following saphenous vein blood collection on GD20, dams were sacrificed and trunk blood was collected along with maternal tissue specimens from cerebellum, heart, lung, kidney and liver. The placenta, amniotic fluid and fetal brain were also collected. Results demonstrated that maternal saphenous blood toluene levels increased as the inhaled concentration of toluene and duration of exposure increased. The maternal cerebellum, heart, kidney and liver appeared to be saturated after 30 min on GD20 such that toluene levels in those organs were equivalent across all ambient concentrations of inhaled toluene. Toluene levels also increased in fetal brain as the inhaled concentration of toluene increased and in placenta and amniotic fluid as the duration of exposure increased. Toluene levels in all tissues at GD20, except maternal lung and amniotic fluid, were higher than in maternal saphenous blood suggesting that toluene concentrated in those organs. Measurement of toluene levels in blood and other tissues following repeated toluene exposure demonstrated that toluene readily reaches a variety of potential sites of action throughout the maternal-placental-fetal unit.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17669620      PMCID: PMC2137922          DOI: 10.1016/j.reprotox.2007.06.005

Source DB:  PubMed          Journal:  Reprod Toxicol        ISSN: 0890-6238            Impact factor:   3.143


  57 in total

Review 1.  Clinical review of inhalants.

Authors:  T Brouette; R Anton
Journal:  Am J Addict       Date:  2001

2.  Adolescent inhalant abuse: environments of use.

Authors:  E L McGarvey; G J Clavet; W Mason; D Waite
Journal:  Am J Drug Alcohol Abuse       Date:  1999-11       Impact factor: 3.829

Review 3.  Inhalant abuse by adolescents.

Authors:  T L Kurtzman; K N Otsuka; R A Wahl
Journal:  J Adolesc Health       Date:  2001-03       Impact factor: 5.012

4.  Inhalant abuse among American Indian, Mexican American, and non-Latino white adolescents.

Authors:  Fred Beauvais; Jeffrey C Wayman; Pamela Jumper-Thurman; Barbara Plested; Heather Helm
Journal:  Am J Drug Alcohol Abuse       Date:  2002       Impact factor: 3.829

Review 5.  Review of the epidemiological evidence relating toluene to reproductive outcomes.

Authors:  J A Bukowski
Journal:  Regul Toxicol Pharmacol       Date:  2001-04       Impact factor: 3.271

6.  Gestational toluene exposure effects on spontaneous and amphetamine-induced locomotor behavior in rats.

Authors:  Scott E Bowen; Michael H Mohammadi; Jeffery C Batis; John H Hannigan
Journal:  Neurotoxicol Teratol       Date:  2006-10-06       Impact factor: 3.763

7.  Prenatal exposure to toluene results in abnormal neurogenesis and migration in rat somatosensory cortex.

Authors:  S M Gospe; S S Zhou
Journal:  Pediatr Res       Date:  2000-03       Impact factor: 3.756

8.  Developmental toxic effects of ethylbenzene or toluene alone and in combination with butyl acetate in rats after inhalation exposure.

Authors:  Anne-Marie Saillenfait; Frédéric Gallissot; Jean-Philippe Sabaté; Nathalie Bourges-Abella; Samuel Muller
Journal:  J Appl Toxicol       Date:  2007 Jan-Feb       Impact factor: 3.446

9.  A lung model describing uptake of organic solvents and roles of mucosal blood flow and metabolism in the bronchioles.

Authors:  S Kumagai; I Matsunaga
Journal:  Inhal Toxicol       Date:  2000-06       Impact factor: 2.724

10.  Developmental neurotoxicity: do similar phenotypes indicate a common mode of action? A comparison of fetal alcohol syndrome, toluene embryopathy and maternal phenylketonuria.

Authors:  L G Costa; M Guizzetti; M Burry; J Oberdoerster
Journal:  Toxicol Lett       Date:  2002-02-28       Impact factor: 4.372

View more
  5 in total

1.  Alterations in rat fetal morphology following abuse patterns of toluene exposure.

Authors:  Scott E Bowen; Susan Irtenkauf; John H Hannigan; Adrianne L Stefanski
Journal:  Reprod Toxicol       Date:  2009-01-21       Impact factor: 3.143

2.  Differential effects of inhaled toluene on locomotor activity in adolescent and adult rats.

Authors:  Jeffery C Batis; John H Hannigan; Scott E Bowen
Journal:  Pharmacol Biochem Behav       Date:  2010-07-15       Impact factor: 3.533

3.  Binge toluene exposure in pregnancy and pre-weaning developmental consequences in rats.

Authors:  Scott E Bowen; John H Hannigan
Journal:  Neurotoxicol Teratol       Date:  2013-04-15       Impact factor: 3.763

4.  Binge toluene exposure alters glutamate, glutamine and GABA in the adolescent rat brain as measured by proton magnetic resonance spectroscopy.

Authors:  Shane A Perrine; Shonagh K O'Leary-Moore; Matthew P Galloway; John H Hannigan; Scott E Bowen
Journal:  Drug Alcohol Depend       Date:  2010-12-03       Impact factor: 4.492

5.  Characterization of an inhaled toluene drug discrimination in mice: effect of exposure conditions and route of administration.

Authors:  Keith L Shelton; Galina Slavova-Hernandez
Journal:  Pharmacol Biochem Behav       Date:  2009-03-04       Impact factor: 3.533

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.